[go: up one dir, main page]

WO2006094770A2 - Apparatus and method for the final processing of a forming tool for a sheet-metal body part - Google Patents

Apparatus and method for the final processing of a forming tool for a sheet-metal body part Download PDF

Info

Publication number
WO2006094770A2
WO2006094770A2 PCT/EP2006/002090 EP2006002090W WO2006094770A2 WO 2006094770 A2 WO2006094770 A2 WO 2006094770A2 EP 2006002090 W EP2006002090 W EP 2006002090W WO 2006094770 A2 WO2006094770 A2 WO 2006094770A2
Authority
WO
WIPO (PCT)
Prior art keywords
nmr
compound
mmol
mhz
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/002090
Other languages
French (fr)
Other versions
WO2006094770A3 (en
Inventor
Franz Ferdinand Paintner
Patricia Klemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Maximilians Universitaet Muenchen LMU
Original Assignee
Ludwig Maximilians Universitaet Muenchen LMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Maximilians Universitaet Muenchen LMU filed Critical Ludwig Maximilians Universitaet Muenchen LMU
Publication of WO2006094770A2 publication Critical patent/WO2006094770A2/en
Publication of WO2006094770A3 publication Critical patent/WO2006094770A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Definitions

  • the present invention is directed to a process for the preparation of (4S)- or (4R)-2,2- dimethyl-4-(2-hydroxethyl)oxazolidine-3-carboxylic acid alkyl esters.
  • the invention is further directed to an intermediate product from which those alkyl esters may be obtained.
  • 4-Hydroxyornithine is a rare amino acid found in lentils 1 (e.g. Lens culinaris Medik.) and some members of the genus Vicia 2 (e.g. V. unijuga A. Br.).
  • the structure of (2S,4R)-4- hydroxyornithine is given in Figure 1 below.
  • it is a key constituent of the ⁇ -lactam antibiotic clavalanine 3 and the cyclopeptide antibiotics biphenomycin A and B I 4 (see Scheme 1). The latter have received considerable attention in recent years due to their high in vitro and in vivo antibacterial activity against multiresistant gram-positive pathogens.
  • the inventors sought, as part of their program directed towards a convergent total synthesis of these antibiotics 6 and analogues thereof with modified biaryl moiety, for an efficient access to an appropriate TV 0 ⁇ iV 8 , unprotected (25,4i?)-4-hydroxyornithine building block. While a number of synthetic pathways including stereoselective approaches have been developed for the synthesis of 4-hydroxyornithine 7 , only two approaches dealt with the synthesis of a derivative bearing N a , ⁇ ' ⁇ ,O ⁇ -protection suitable for peptide synthesis.
  • N,0-acetal 9 was shown to exist also in an equilibrium with its 1 -methyl- 1 -methoxyethyl (MIP) ether derivative 11, a fact not mentioned in the previous papers. 17 In the end, trapping 9 to form 11 allows the overall equilibrium to be shifted to the desired five-membered ring system.
  • MIP 1 -methyl- 1 -methoxyethyl
  • the inventors of the present invention have found, that the trapping of liberated reaction product, i.e. methanol in this embodiment, could shift the equilibrium of 9 and 11 to the side of the derivative 11 (compound (V)).
  • the trapping of the reaction side product, i.e. the liberated alcohol of the diester shifts the equilibrium towards derivative 11.
  • the desired product 9 (compound (I)) can easily be obtained from 11. Since product 9 is withdrawn from the equilibrium between the isomers 8, 9 and 10, this equilibrium is shifted towards the desired product 9.
  • the liberated alcohol can be trapped by 2- methoxypropene to produce 2,2-dimethoxypropane.
  • the reaction conditions are modified in such a way that 2,2-dimethoxypropane is used as the solvent and 2-methoxypropene (3.0 equiv.) is added to trap liberated methanol.
  • the desired product 9 can be obtained in high overall yield (92%) after mild hydrolysis (wet silica gel, CH 2 Cl 2 , rt) of the intermediate MIP ether 11.
  • R 1 is methyl, ethyl, 2,2,2-trichloroethyl, 2-trimethylsilylethyl, tert-butyl, 1-adamantyl, allyl, 9-fluorenylmethyl, benzyl or a substituted benzyl group;
  • R 2 is methyl or ethyl, in the presence of an acid to give a compound of formula (V) or its enantiomer wherein:
  • R 1 and R 2 are as defined above, which is hydrolyzed to give a compound of formula (I).
  • R 2 can be methyl or ethyl, with methyl being preferred.
  • R is defined as above.
  • R is identical in both the 2,2-dialkoxypropane of formula (III) and the 2-alkoxypropene according to formula (IV). It is important to note that both compounds (III) and (IV) have to be present in the process of the invention in order to achieve the object of the invention, i.e. to obtain compound (V) and, finally, compound (I) in a high yield.
  • an acid is added according to the invention.
  • This acid preferably is soluble in the solvent used.
  • a preferred acid is p-toluenesulfonic acid.
  • other acids may be used, for example camphorsulfonic acid.
  • 2,2-dialkoxypropane can be used according to the invention.
  • the solvent further acts as a reagent to form the desired product 9.
  • further solvents may be used in the process of the invention.
  • dichloromethane and acetone should be named. Any solvent may be used as long as it is compatible with strong acids and as long as it is possible to remove water therefrom.
  • any protected (S)- or (R)-2-amino-l ,4-butandiol corresponding to formula (II) below may be used.
  • R 1 is methyl, ethyl, 2,2,2-trichloroethyl, 2-trimethylsilylethyl, tert-butyl, 1-adamantyl, allyl, 9-fluorenylmethyl, benzyl or a substituted benzyl group, with tert-butyl being preferred.
  • R 1 is methyl, ethyl, 2,2,2-trichloroethyl, 2-trimethylsilylethyl, tert-butyl, 1- adamantyl, allyl, 9-fluorenylmethyl, benzyl or a substituted benzyl group, preferably tert- butyl.
  • the present invention provides the compound of formula (V) or its enantiomer, wherein R and R are as defined above.
  • Compound (V) turned out to be a very useful intermediate, since its production and isolation by the present process shifts the equilibrium of the reaction (see scheme 4) in order to result in compound (V) in high yield.
  • R 1 is tert-buty ⁇ and/or R 2 is methyl.
  • aldehyde 6 was reacted with nitromethane in the presence of the enantiomeric catalysts ⁇ Cu[(-)-15] ⁇ (OAc) 2 and ⁇ Cu[(-)-16] ⁇ (OAc) 2 respectively. In these cases slightly lower stereoselectivities and yields were observed reflecting a mismatched pairing (Table 1, entries 6 and 8).
  • Fig. 1 is an 1 H NMR spectrum (500 MHz, CD 2 Cl 2 ) of compound 8;
  • Fig. 2 is an 13 C NMR spectrum (125 MHz, CD 2 Cl 2 ) of compound 8;
  • Fig..3 is an 1 H- 13 C HMQC spectrum (CD 2 Cl 2 ) of compound 8;
  • Fig. 4 is an 1 H- 13 C HMBC spectrum (CD 2 Cl 2 ) of compound 8;
  • Fig. 5 is an 1 H- 15 N HMQC spectrum (CD 2 Cl 2 ) of compound 8.
  • Fig. 6 is an 1 H NMR spectrum (500 MHz, C 2 D 2 Cl 4 , 80 0 C) of compound 5.
  • N-Boc-protected (5)-2-amino-l,4-butandiol 7 was prepared from aspartic acid in 3 steps in 95% overall yield using previously reported methods, shown in Scheme 7 below.
  • Example 1 A solution of 7 (13.36 g, 65.1 mmol) and j7-toluenesulfonic acid monohydrate (632 mg, 3.32 mmol) in 2,2-dimethoxypro ⁇ ane (650 mL) was stirred at room temperature for 2 h. 2-Methoxypropene (20 mL, 209 mmol) was added and the reaction mixture was stirred for additional 67 h at room temperature. The solution then was poured into cold saturated aqueous NaHCO 3 (900 mL) and extracted with EtOAc (5 x 300 mL). The combined organic layers were dried (MgSO 4 ) and concentrated in vacuo to give 11 as a colorless oil which was used without further purification.
  • 2-Methoxypropene (20 mL, 209 mmol) was added and the reaction mixture was stirred for additional 67 h at room temperature.
  • the solution then was poured into cold saturated aqueous NaHCO 3 (900 mL) and extracted with EtOAc
  • Example 2 2,2-Dimethoxypropane (2.53 mL, 20 mmol) and DL-camphor-10-sulfonic acid (23.7 mg, 0.1 mmol) were added to a stirred solution of diol 7 (410 mg, 2.0 mmol) in CH 2 Cl 2 (5 mL). After stirring for 6 h at room temperature 2-methoxypropene (670 ⁇ l, 7 mmol) was added. After stirring for further 20 h the reaction mixture was poured into saturated aqueous NaHCO 3 (10 mL) and extracted with CH 2 Cl 2 (5 x 30 mL). The combined organic layers were dried (MgSO 4 ) and concentrated in vacuo to give 11 as a colorless oil (665 mg) which was used without further purification.
  • Example 3 2,2-Dimethoxypropane (2.53 mL, 20 mmol) and DL-camphor-10-sulfonic acid (23.7 mg, 0.1 mmol) were added to a stirred solution of diol 7 (410 mg, 2.0 mmol) in acetone (5 mL). After stirring for 6 h at room temperature 2-methoxypropene (670 ⁇ l, 7 mmol) was added. After stirring for further 20 h the reaction mixture was poured into saturated aqueous NaHCO 3 (10 mL) and extracted with CH 2 Cl 2 (5 x 30 mL). The combined organic layers were dried (MgSO 4 ) and concentrated in vacuo to give 11 as a colorless oil (646 mg) which was used without further purification.
  • the crude product was purified by flash chromatography on silica gel (/?-hexane:EtOAc 3:1) to give 12 (6.87 g, 94%) as a 97:3 mixture of diastereomers.
  • TIPSOTf (1.5 mL, 5.25 mmol) was added dropwise to a cooled solution (0 0 C) of alcohol 12 (1.52 g, 5.0 mmol, 97:3 mixture of diastereomers) and 2,6-Lutidine (680 ⁇ l, 5.75 mmol) in CH 2 Cl 2 (1O mL). The reaction mixture was stirred for 90 min at 0 0 C and for 15 h at room temperature before it was quenched with saturated aqueous NaHCO 3 . The layers were separated and the aqueous layer was extracted with diethyl ether (5 x 20 mL). The combined organic layers were dried (MgSO 4 ), filtered and concentrated in vacuo.
  • N-(Benzyloxy-carbonyloxy)succinimide (1.24 g, 4.88 mmol) was added to a solution of the crude amine and Et 3 N (850 ⁇ l, 6.04 mmol) in CH 2 Cl 2 (15 mL). After stirring for 70 h at room temperature the reaction mixture was diluted with EtOAc (50 mL) and washed with phosphate buffer pH 5.5 (30 mL). The organic layer was dried (MgSO 4 ), filtered and concentrated in vacuo.
  • Nitroaldol adduct 13 was prepared from aldehyde 6 (243 mg, 1.0 mmol) and nitromethane (0.55 mL, 10.0 mmol) in the presence of indabox ligand (-)-16 (19.7 mg, 0.055 mmol) and Cu(OAc) 2 -H 2 O (10.0 mg, 0.05 mmol) as described for diastereomer 12.
  • the crude product was purified by flash chromatography on silica gel (/j-hexane:EtOAc 3:1) to give 13 (211 mg, 91%) as a 92:8 mixture of diastereomers.
  • TlPSO NHBoc nyl-aminopent-2-ylaminocarboxylic acid tert-butyl ester (23) A solution of 22 (1.412 g, 2.5 mmol) and pyridinium /7-toluene sulfonate (377 mg, 1.5 mmol) in dry MeOH (20O mL) was stirred at 60 0 C for 4.5 h. The reaction mixture was cooled to room temperature and the solvent was removed in vacuo. The residue was dissolved in EtOAc (300 mL) and washed with saturated aqueous NaHCO 3 . The organic layer was dried (MgSO 4 ), filtered, and concentrated in vacuo.
  • TIPSO NHBoc 4-triisopropyIs ⁇ anyloxy-pentanoic acid (5) Carboxylic acid 5 was prepared from alcohol 23 (787 mg, 1.5 mmol) by oxidation with

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Mounting, Exchange, And Manufacturing Of Dies (AREA)

Abstract

The present invention is directed to a process for the preparation of (4S)- or (4R)-2,2-dimethyl-4-(2-hydroxethyl)oxazolidine-3-carboxylic acid alkyl esters. The invention is further directed to an intermediate product from which those alkyl esters may be obtained.

Description

IMPROVED PROCEDURE FOR THE PREPARATION OF
(4S) OR (4R) -2,2-DIMETHYL-4- (2-HYDROXYETHYL) OXAZOLIDINE-S-CARBOXYLIC ACID ALKYL ESTERS
The present invention is directed to a process for the preparation of (4S)- or (4R)-2,2- dimethyl-4-(2-hydroxethyl)oxazolidine-3-carboxylic acid alkyl esters. The invention is further directed to an intermediate product from which those alkyl esters may be obtained.
4-Hydroxyornithine is a rare amino acid found in lentils1 (e.g. Lens culinaris Medik.) and some members of the genus Vicia2 (e.g. V. unijuga A. Br.). The structure of (2S,4R)-4- hydroxyornithine is given in Figure 1 below. Moreover it is a key constituent of the β-lactam antibiotic clavalanine3 and the cyclopeptide antibiotics biphenomycin A and B I4 (see Scheme 1). The latter have received considerable attention in recent years due to their high in vitro and in vivo antibacterial activity against multiresistant gram-positive pathogens.
Figure imgf000002_0001
Scheme 1: Structures of 4-hydroxyornithine and biphenomycin A and B
The inventors sought, as part of their program directed towards a convergent total synthesis of these antibiotics6 and analogues thereof with modified biaryl moiety, for an efficient access to an appropriate TV0^iV8, unprotected (25,4i?)-4-hydroxyornithine building block. While a number of synthetic pathways including stereoselective approaches have been developed for the synthesis of 4-hydroxyornithine7, only two approaches dealt with the synthesis of a derivative bearing Na,Λ'δ,Oγ-protection suitable for peptide synthesis.
Schmidt et al. reported a 13 step synthesis starting from (/?)-isopropylidene glyceraldehyde to form the Λζ,O-acetal 2 (see Scheme 2) albeit in low overall yield.8 More recently Rudolph et al. described a very concise access to the TBDMS protected 4-hydroxyornithine 3 starting from (S)-N-BoC aspartic acid tert-buty\ ester. This approach which is based on an initial homologization of the acid side chain to form an α-nitroketone and its subsequent diastereo- selective reduction to the corresponding β-nitro alcohol, however, also suffers from a low overall yield.5'9
--V0 NHBoc TBDMSO NHBoc
2 3
Scheme 2: Protected forms of 4-hydroxyornithine
In this application, a short and efficient stereoselective approach to both orthogonally
Figure imgf000003_0001
(2S,4R)- and (25I,46)-4-hydroxyornithine based on an asymmetric nitroaldol (Henry) reaction of nitromethane with the homoserine derived aldehyde 610 (Scheme 3) ' is disclosed. A retrosynthetic analysis of the nitroaldol reaction is given in Scheme 3 below.
reaction
Figure imgf000003_0002
5
Scheme 3: Retrosynthetic Analysis
A simple two-step preparation of building block 6 starting from readily available N-Boc- protected (S)-2-amino-l,4-butandiol 712 was previously reported by Ksander and co- workers.13'14 This commonly used approach, however, suffers from a low regioselectivity in the formation of the five-membered cyclic N,O-acetal 9 (Scheme 4). Thus, this crucial step was reported to proceed in only 42-48% yield by reacting 7 with excess 2,2-dimeth- oxypropane (DMP) (10 equiv., CH2Cl2, rt) in the presence of a catalytic amount of p-toluene sulfonic acid (TsOH), due to concurrent formation of the corresponding six-membered cyclic JV,O-acetal 10.13'15 Therefore, it is an object of the present invention to provide a new process for the preparation of compound (I) indicated below in high yield:
Figure imgf000004_0001
(I)
which can be used as a starting material to obtain hydroxyornithine. It is a further object to provide an intermediate product for the above given process.
These objects are solved by the subject-matter of the independent claims. Preferred embodiments are set forth in the dependent claims.
The present inventors based their improved process for obtaining the compound of formula (I) on the following considerations:
Figure imgf000004_0002
DMP Ii MeOH
Figure imgf000004_0003
Scheme 4: Acid Catalyzed N,OAcetal Formation of N-Boc-Protected (S)-2 -Amino- 1,4- butandiol 7 with DMP (it is noted that in scheme 4, compound 9 corresponds to the above compound (I) and compound 11 corresponds to the compound which is also termed "compound (V)" in the following). The inventors surprisingly found out in the course of their studies that the structure of this byproduct 10 (outlined above) was revised on the basis of 1H-13C HMBC and 1H-15N HMQC NMR experiments to be the corresponding seven-membered cyclic 0,0-acetal 8. Indeed, this isomer was shown to be the product of kinetic control, which slowly equilibrates with 9 under the reported reaction conditions. No evidence has been found for the occurrence of the six- membered cyclic N,(9-acetal 10.16 Furthermore N,0-acetal 9 was shown to exist also in an equilibrium with its 1 -methyl- 1 -methoxyethyl (MIP) ether derivative 11, a fact not mentioned in the previous papers.17 In the end, trapping 9 to form 11 allows the overall equilibrium to be shifted to the desired five-membered ring system.
The NMR spectra recorded to analyse compounds 5 and 8 are given as Figures.
The inventors of the present invention have found, that the trapping of liberated reaction product, i.e. methanol in this embodiment, could shift the equilibrium of 9 and 11 to the side of the derivative 11 (compound (V)). The trapping of the reaction side product, i.e. the liberated alcohol of the diester, shifts the equilibrium towards derivative 11. The desired product 9 (compound (I)) can easily be obtained from 11. Since product 9 is withdrawn from the equilibrium between the isomers 8, 9 and 10, this equilibrium is shifted towards the desired product 9.
Taking scheme 4 as an example, the liberated alcohol (MeOH) can be trapped by 2- methoxypropene to produce 2,2-dimethoxypropane. Thus, no further product which has to be removed from the resulting reaction mixture is generated while trapping the alcohol. In this example, the reaction conditions are modified in such a way that 2,2-dimethoxypropane is used as the solvent and 2-methoxypropene (3.0 equiv.) is added to trap liberated methanol. The desired product 9 can be obtained in high overall yield (92%) after mild hydrolysis (wet silica gel, CH2Cl2, rt) of the intermediate MIP ether 11. Of course, it is within the average knowledge of someone having ordinary skills in the art that any appropriate 2,2- dialkoxypropane of formula (III) can be used, 2,2-dimethoxypropane is provided as an example only. The present invention thus according to a first aspect provides a process for the preparation of a compound of formula (I) or its enantiomer
Figure imgf000006_0001
(I) wherein:
R1 is methyl, ethyl, 2,2,2-trichloroethyl, 2-trimethylsilylethyl, tert-butyl, 1-adamantyl, allyl, 9-fluorenylmethyl, benzyl or a substituted benzyl group;
which comprises reacting a compound of formula (II) or its enantiomer:
Figure imgf000006_0002
where R1 is as defined above, with an appropriate 2,2-dialkoxypropane of formula (III)
H-C CH,
<oXo-R 2
(III) wherein: R2 is methyl or ethyl and with an appropriate 2-alkoxypropene of formula (IV)
Figure imgf000006_0003
(IV) wherein:
R2 is methyl or ethyl, in the presence of an acid to give a compound of formula (V) or its enantiomer
Figure imgf000007_0001
wherein:
R1 and R2 are as defined above, which is hydrolyzed to give a compound of formula (I).
In formula (III):
H-C CH-
<oXo'R 2
(III)
R2 can be methyl or ethyl, with methyl being preferred.
Further, 2-alkoxypropene according to formula (IV) is used according to the invention.
Figure imgf000007_0002
(IV)
Here, R" is defined as above. Preferably, R is identical in both the 2,2-dialkoxypropane of formula (III) and the 2-alkoxypropene according to formula (IV). It is important to note that both compounds (III) and (IV) have to be present in the process of the invention in order to achieve the object of the invention, i.e. to obtain compound (V) and, finally, compound (I) in a high yield.
In order to catalyse the equilibrium reactions, an acid is added according to the invention. This acid preferably is soluble in the solvent used. A preferred acid is p-toluenesulfonic acid. However, also other acids may be used, for example camphorsulfonic acid.
As a solvent, 2,2-dialkoxypropane can be used according to the invention. In this embodiment, the solvent further acts as a reagent to form the desired product 9. However, also further solvents may be used in the process of the invention. As preferred examples, dichloromethane and acetone should be named. Any solvent may be used as long as it is compatible with strong acids and as long as it is possible to remove water therefrom.
As starting material, any protected (S)- or (R)-2-amino-l ,4-butandiol corresponding to formula (II) below may be used.
Figure imgf000008_0001
Here, R1 is methyl, ethyl, 2,2,2-trichloroethyl, 2-trimethylsilylethyl, tert-butyl, 1-adamantyl, allyl, 9-fluorenylmethyl, benzyl or a substituted benzyl group, with tert-butyl being preferred.
The above described process can thus be used to prepare a compound of the formula (I)
Figure imgf000008_0002
(I) wherein R1 is methyl, ethyl, 2,2,2-trichloroethyl, 2-trimethylsilylethyl, tert-butyl, 1- adamantyl, allyl, 9-fluorenylmethyl, benzyl or a substituted benzyl group, preferably tert- butyl.
Finally Swern oxidation of 9 provides the desired aldehyde 6 in 97% yield (Scheme 5).14
3 stePl
Figure imgf000009_0001
Figure imgf000009_0002
Figure imgf000009_0003
(COCI)2, DMSO, NEt3, H
CH2CI2, -60 0C "Tf Y o >- O BocN-^—
97% 6 /
Scheme 5: Improved Synthesis of Aldehyde 6
In a second aspect, the present invention provides the compound of formula (V) or its enantiomer, wherein R and R are as defined above. Compound (V) turned out to be a very useful intermediate, since its production and isolation by the present process shifts the equilibrium of the reaction (see scheme 4) in order to result in compound (V) in high yield. Second, it may be easily converted to the desired compound (I) by simple hydrolysis.
According to an embodiment, in this compound, R1 is tert-buty\ and/or R2 is methyl.
With key building block 6 in hand, its nitroaldol (Henry) reaction with nitromethane was examined (Table 1). LiAlH4 18- TBAF19- as well as t-BuOK20-catalyzed Henry reactions led to nitro alcohols 12 and 13 with low diastereoselectivity, reflecting that the existing stereogenic center is too far away from the newly created one to exert appreciable asymmetric induction (Table 1, entries 1-3).21 An obvious way of resolving this problem was the introduction of additional chiral information, i.e. application of a chiral catalyst. In fact double stereodifferentiation using Shibasaki's well established heterobimetallic (,S)-BINOL catalyst 1422 (5 mol%, THF, -40 °C, 3 d) led to 12 with high diastereoselectivity albeit in low yield (Table 1, entry 4).
Recently, other highly efficient chiral catalysts for asymmetric Henry reactions have been developed. Thus, Corey23 and Maruoka24 have utilized chiral quaternary ammonium fluorides as catalysts while Trost25 has presented a dinuclear zinc catalyst. Salen-cobalt(II) complexes have been used by Yamada whereas Jørgensen and Evans have introduced bis(oxazoline)-copρer(II) complexes. The latter seemed to be the catalysts of choice, at least for aliphatic aldehydes, with respect to attainable yields and degree of stereoselectivity. Table 1. Diastereoselective Henry Reaction of Aldehyde 6 with Nitromethane
Figure imgf000010_0001
yield ratio0 entry catalyst conditions
(%)a 12:13
1 LiAlH4 THF, rt 53 56:44
2 TBAF THF, rt 33 43:57
3 r-BuOK t- 72 23:77
BuOH/THF,0
0C
4 14 THF, -40 °C 45 98:2
5 {Cu[(+> EtOH, rt 87 92:8
15]} (OAc)2
6 (CuK-)- EtOH, rt 85 9:91
15]}(OAc)2
7 {Cu[(+> EtOH, rt 94 97:3
16]}(OAc)2
8 (Cu[(-)- EtOH, rt 91 8:92
16I)(OAc)2
a isolated yield b determined by HPLC analysis of crude reaction mixtures Indeed application of Evans' bis(oxazoline) copper(II) acetate-based catalysts {Cu[(+)- 15]}(OAc)2 and in particular {Cu[(+)-16]}(OAc)2 (5 mol%, EtOH, rt, 5 d) gave the desired nitro alcohol 12 both with high diastereoselectivity and in high yield (Table 1 , entries 5 and 7). Finally, to obtain selectively diastereomer 13, aldehyde 6 was reacted with nitromethane in the presence of the enantiomeric catalysts {Cu[(-)-15]}(OAc)2 and {Cu[(-)-16]} (OAc)2 respectively. In these cases slightly lower stereoselectivities and yields were observed reflecting a mismatched pairing (Table 1, entries 6 and 8).
Figure imgf000011_0001
17
1. (CH2OH)2 , CSA (cat.), THF, 50 0C
2. TEMPO (cat.), NaOCI (cat.), NaCIO2, MeCN, buffer pH 6.7 ZHN^ C0*H TIPSO NHBoc
53% (80%)a 4
Figure imgf000011_0002
1 based on recovered starting material
Scheme 6: Synthesis of Orthogonally Protected (25',4i?)-4-Hydroxyornithine 4
The inventors next turned their attention to the transformation of β-nitro alcohol 12 into the desired amino acid building block 4 (Scheme 6).29 Protection of the hydroxyl group as a TIPS ether proceeded smoothly under standard conditions (TIPSOTf/2,6-lutidine). Reduction of the nitro group was accomplished using ammonium formate as a hydrogen source, and palladium on carbon as the catalyst to afford the corresponding amine which was transformed (Z-OSu/NEt3) to the Λ^-Z-protected 4-hydroxyornithine derivative 17 in 84% overall yield (three steps). Selective hydrolysis of the N,0-acetal using several methods (e.g. pyridinium tosylat, MeOH, 60 °C; I2, MeOH, rt or CeCl3"7H2O/oxalic acid, rt) proved to be difficult due to concomitant partial cleavage of the TIPS ether. Fortunately, the inventors were able to effect this transformation cleanly and in good yield (64%, 96% based on recovered starting material) using ethylene glycol/CSA (THF5 50 °C, 2d).30 The final oxidation of the amino alcohol was best accomplished with TEMPO/ΝaOCl/ΝaClθ2 31 to give the desired carboxylic acid 4 {mp 45-47 0C5 [oc]22 D +67.6 (c 1.64, CH2Cl2)) in 83% yield without epimerization. The absolute configuration of product 4 was established to be 2S,4R by subsequent transformation into the known γ-lactone 1832 {mp 148-149 0C lit. 143-145 °C; [α]D 23 -25.2 (c 0.85, CHCl3) lit. [α]D 23 -22.4 (c 0.5, CHCl3)).
0C\
According to this reaction sequence, 13 was converted to 5 {mp 53-55 0C, [α] D -28.5 (c 1.00, CH2Cl2)) in 57% overall yield {66% based on recovered starting materials) in five steps.
In conclusion the inventors have developed a short and highly efficient approach to orthogonally protected (2S,4R)- and (25',45)-4-hydroxyornithine building blocks 4 and 5 respectively based on bis(oxazoline) copper(II) complex catalyzed diastereoselctive Henry reactions of nitromethane with aldehyde 6. In addition, a greatly improved procedure for a multigram synthesis of this valuable chiral building block and its precursor 9 has been developed.
The present invention is now illustrated in greater detail by the enclosed Figures and Examples. It is noted that the Examples are provided for illustrative purposes only and that the invention is not limited thereto.
In the Figures, the following is shown:
Fig. 1 is an 1H NMR spectrum (500 MHz, CD2Cl2) of compound 8;
Fig. 2 is an 13C NMR spectrum (125 MHz, CD2Cl2) of compound 8;
Fig..3 is an 1H-13C HMQC spectrum (CD2Cl2) of compound 8;
Fig. 4 is an 1H-13C HMBC spectrum (CD2Cl2) of compound 8;
Fig. 5 is an 1H-15N HMQC spectrum (CD2Cl2) of compound 8; and
Fig. 6 is an 1H NMR spectrum (500 MHz, C2D2Cl4, 80 0C) of compound 5.
Examples:
General information. All reactions were carried out in oven-dried glassware under a nitrogen atmosphere unless stated otherwise. THF and NEt3 were distilled from sodium, EtOH from sodium/ethyl phthalate, MeOH from magnesium and CH2Cl2 from calcium hydride immediately before use. Standard syringe techniques were applied for transferring anhydrous solvents. Indabox ligands (+)-16 and (-)-16 were prepared using literature procedures.33 All other solvents and reagents were used as supplied. Analytical thin layer chromatography was performed on Merck 0.25 mm silica gel 60-F254 plates. Visualization was accomplished with UV light and either eerie ammonium nitrate or permanganat stain, followed by heating. Purification of reaction products was carried out by flash chromatography using Merck silica gel 60 (40-63 μm). Melting points were obtained on a melting point apparatus Bϋchi No. 510 (Dr. Tottoli) and are uncorrected. Optical rotations were measured on a Perkin Elmer Model 241 polarimeter at 589 nm and are reported as follows: [α]τ °C D (c = g/100 mL, solvent). Infrared spectra were recorded on a Perkin Elmer FT-IR Spectrometer Paragon 1000. 1H NMR spectra were recorded on a Jeol JNMR-GX400 (400 MHz) or on a Jeol JNMR-GX500 (500 MHz) spectrometer. Chemical shifts are reported in ppm using TMS as internal standard. Chemical shifts of high temperature 1H NMR spectra are reported in ppm using solvent as an internal standard (C2D2Cl4 at 5.99 ppm). Data are reported as s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, b = broad; coupling constant(s) in Hz; integration. Proton-decoupled 13C NMR spectra were recorded on a Jeol JNMR-GX400 (100 MHz) or on a Jeol JNMR-GX500 (125 MHz) spectrometer. Chemical shifts are reported in ppm using TMS as internal standard. Chemical shifts of high temperature ]3C NMR spectra are reported in ppm using solvent as an internal standard (C2D2Cl4 at 73.99 ppm). Mass spectra were obtained on a Hewlett Packard 5989A mass spectrometer with 59980B Particle Beam LC/MS Interface. High resolution mass spectra were obtained on a Jeol MStation 700. Combustion elemental analyses were measured on a Heraeus CHN Rapid.
The N-Boc-protected (5)-2-amino-l,4-butandiol 7 was prepared from aspartic acid in 3 steps in 95% overall yield using previously reported methods, shown in Scheme 7 below.
Figure imgf000014_0001
Scheme 7: Synthesis of iV-Boc-protected (S)-2-amino-l,4-butandiol 7
Synthesis of iV,0-acetal 9 according to literature (comparative example):3 2,2-
Dimethoxypropane (1.2 mL, 10 mmol) and /?-toluenesulfonic acid monohydrate (19 mg, 0.1 mmol) were added to a stirred solution of diol 7 (205 mg, 1.0 mmol) in CH2Cl2 (4.5 mL). After stirring for 36 h at room temperature the reaction mixture was poured into saturated aqueous NaHCO3 (5 mL) and extracted with EtOAc (5 x 5 mL). The combined organic layers were dried (MgSO4) and concentrated in vacuo to give a colorless oil. The ratio of 8:9:11 was determined by 1H NMR (500 MHz) to be 30:45:25. The residue was purified by flash chromatography on silica gel («-hexane/EtOAc 80:20 + 0.5% iV-ethyldimethylamine) to afford N,O-acetal 9 (110 mg, 45%) as a colorless solid along with 0,<9-acetal 8 (47 mg, 19%) as a colorless oil and MIP derivative 11 (50 mg, 16%) as a colorless oil, which is prone to hydrolysis.
Example 1: A solution of 7 (13.36 g, 65.1 mmol) and j7-toluenesulfonic acid monohydrate (632 mg, 3.32 mmol) in 2,2-dimethoxyproρane (650 mL) was stirred at room temperature for 2 h. 2-Methoxypropene (20 mL, 209 mmol) was added and the reaction mixture was stirred for additional 67 h at room temperature. The solution then was poured into cold saturated aqueous NaHCO3 (900 mL) and extracted with EtOAc (5 x 300 mL). The combined organic layers were dried (MgSO4) and concentrated in vacuo to give 11 as a colorless oil which was used without further purification. A solution of the crude product 11 in CH2Cl2 (400 mL) was treated with silica gel (166 g) and H2O (1O mL) and stirred at room temperature for 72 h. After filtration through a pad of sand the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel (π-hexane/EtOAc 80:20 + 0.5% ethyldimethylamine) to afford N,O-acetal 9 as a colorless solid (14.64 g, 92%) along with 0,0-acetal 8 (0.35 g, 2%) as a colorless oil.
Example 2: 2,2-Dimethoxypropane (2.53 mL, 20 mmol) and DL-camphor-10-sulfonic acid (23.7 mg, 0.1 mmol) were added to a stirred solution of diol 7 (410 mg, 2.0 mmol) in CH2Cl2 (5 mL). After stirring for 6 h at room temperature 2-methoxypropene (670 μl, 7 mmol) was added. After stirring for further 20 h the reaction mixture was poured into saturated aqueous NaHCO3 (10 mL) and extracted with CH2Cl2 (5 x 30 mL). The combined organic layers were dried (MgSO4) and concentrated in vacuo to give 11 as a colorless oil (665 mg) which was used without further purification. A solution of the crude product 11 in CH2Cl2 (12 mL) was treated with silica gel (5 g) and H2O (0.3 mL) and stirred at room temperature for 96 h. After filtration through a pad of sand the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel (π-hexane/EtOAc 80:20 + 0.5% ethyldimethylamine) to afford N,O-aceta\ 9 as a colorless solid (469 g, 96%).
Example 3: 2,2-Dimethoxypropane (2.53 mL, 20 mmol) and DL-camphor-10-sulfonic acid (23.7 mg, 0.1 mmol) were added to a stirred solution of diol 7 (410 mg, 2.0 mmol) in acetone (5 mL). After stirring for 6 h at room temperature 2-methoxypropene (670 μl, 7 mmol) was added. After stirring for further 20 h the reaction mixture was poured into saturated aqueous NaHCO3 (10 mL) and extracted with CH2Cl2 (5 x 30 mL). The combined organic layers were dried (MgSO4) and concentrated in vacuo to give 11 as a colorless oil (646 mg) which was used without further purification. A solution of the crude product 11 in CH2Cl2 (12 mL) was treated with silica gel (5 g) and H2O (0.3 mL) and stirred at room temperature for 96 h. After filtration through a pad of sand the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel («-hexane/EtOAc 80:20 + 0.5% ethyldimethylamine) to afford N,O-acetal 9 as a colorless solid (442 g, 90%).
(45)-2,2-Dimethyl-4-(2-hydroxyethyl)-oxazolidine-3-carboxylic acid tert-bntyl ester (9): tnp 75-76°C; [α]19 D -12.3 (c 1.53, CHCl3) lit.35 [α]D
Figure imgf000015_0001
+12.1 (c 1.5, CHCl3) [(Λ)-isomer]; 1H ΝMR (500 MHz, CDCl3): δ 1.50 (s, 9 H), 1.51 (s, 3 H), 1.55 (s, 3 H), 1.68-1.77 (m, 1 H), 1.78-1.89 (m, 1 H), 3.50-3.60 (m, 1 H), 3.60-3.77 (m, 2 H), 4.01 (m, 1 H), 4.23 (m, 1 H); 13C ΝMR (100 MHz, CDCl3): δ 24.4 (CH3), 27.8 (CH3), 28.3 (CH3), 37.8 (CH2), 53.9 (CH), 58.7 (CH2), 68.3 (CH2), 81.0 (C), 93.7 (C), 153.9 (C). The spectroscopic data were consistent with those reported.2
(5S)-2,2-Dimethyl-l,3-dioxepane-5-carbaminic acid tert-butyl ester (8): [(X]23D +0.16 (c 1.25, CH2Cl2); IR (film): 3452 cm"1, 1713; 1H NMR
Figure imgf000016_0001
(50° MHz' CDCl3): δ 1.32 (s, 3 H), 1.34 (s, 3 H), 1.45 (s, 9 H), 1.70 (bd, J
= 14.3 Hz, IH), 1.77 (ddt, J= 3.7, 10.5, 14.3 Hz, 1 H), 3.53 (ddd, J = 1.8, 4.3, 12.0 Hz, 1 H), 3.59 (dt, J= 3.9, 12.7 Hz, 1 H), 3.73 (bt, J= 1 1.6 Hz, 1 H), 3.74-3.85 (m, 2 H), 5.16 (bd, J= 6.6 Hz, 1 H); 13C NMR (125 MHz, CDCl3): δ 24.7 (CH3), 24.9 (CH3), 28.4 (CH3), 35.8 (CH2), 48.5 (CH), 58.0 (CH2), 64.0 (CH2), 79.3 (C), 101.4 (C), 155.2 (C); 1H NMR (500 MHz, CD2Cl2): δ 1.29 (s, 3 H), 1.30 (s, 3 H), 1.42 (s, 9 H), 1.63 (dtt, J= 1.8, 4.6, 14.3 Hz, 1 H), 1.74 (dddd, J= 3.3, 4.1, 10.1, 14.3 Hz, 1 H), 3.49 (ddd, J= 1.7, 4.7, 12.0 Hz, 1 H), 3.55 (dddd, J= 0.4, 3.3, 4.6, 12.7 Hz, 1 H), 3.64-3.73 (m, 2 H), 3.75 (bd, J= 12.0 Hz, 1 H), 5.17 (bs, 1 H, NH); 13C-NMR (125 MHz, CD2Cl2): δ 24.6 (CH3), 24.7 (CH3), 28.2 (CH3), 35.9 (CH2), 48.9 (CH), 58.0 (CH2), 64.1 (CH2), 78.9 (C), 101.3 (C), 155.1 (C); MS (CI) m/z (rel. intensity): 246 (4) [M+H]+, 172 (100), 146 (9); Anal. Calcd for C12H23NO4: C, 58.75; H, 9.45; N, 5.71. Found: C, 58.69; H, 9.59; N, 5.74.
1H NMR (500 MHz, CDCl3) and 13C NMR (125 MHz, CDCl3) data match those reported for the six-membered cyclic N.O-acetal 10.2a The structure of 10 was revised on the basis of 1H- 13C HMBC [HMBC cross peaks between δ (H-4) = 3.49, δ (H-7) = 3.55, δ (H-7) ~ 3.70, δ (H- 4) ~ 3.75 and δ (C-2) = 101.6] and 1H-15N HMQC [1H-15N-HMQC cross peak between δ (1H) = 5.17 and δ (15N) = -285 (nitrogen chemical shifts are reported in ppm using nitrobenzene as an external standard)] experiments to be 8, as shown below. For 1H NMR, 13C NMR, 1H- 13C HMQC, 1H-13C HMBC and 1H-15N HMQC spectra of compound 8 (see Figures).
Figure imgf000016_0002
ethyl]- 2,2- dimethyl- ester (11): H NMR
Figure imgf000017_0001
(500 MHz, CDCl3): δ 1.34 (s, 6 H), 1.50 (bs, 12 H), 1.56-1.67 (m,
3 H), 1.71-1.87 (m, 1 H), 1.90-2.16 (m, 1 H), 3.19 (s, 3 H), 3.37-3.63 (m, 2 H), 3.81-4.09 (m, 3 H); 13C-NMR (125 MHz, CDCl3): δ = 24.36 (CH3), 24.39 (CH3), 28.4 (CH3), 28.5 (CH3), 34.1 (CH2), 48.4 (CH3), 55.9 (CH), 58.2 (CH2), 67.4 (CH2), 79.4 (C), 93.7 (C), 99.9 (C), 151.8 (C); HRMS (FAB) calcd for C]6H31NO5 [M+H]+: 318.2280, Found: 318.2280.
(4S)- 2,2- Dimethyl-4- (2-oxoethyI)- oxazolidine-3- carboxylic acid tert- butyl ester (6): A solution of DMSO (5.3 mL, 74.5 mmol) in CH2Cl2
Figure imgf000017_0002
(23 mL) was added dropwise to a cooled solution (-60 °C) of oxalyl chloride (3.44 mL, 40.0 mmol) in CH2Cl2 (83 mL). The solution was stirred for 15 min at -60 °C, before a solution of alcohol 9 (7.017 g, 28.6 mmol) in CH2Cl2 (36 mL, including rinses) was added slowly. After stirring at -60 0C for 30 min, Et3N (19.9 mL, 142.8 mmol) was added. After 30 min, the cold bath was removed and the reaction was stirred an additional hour at room temperature. The mixture was poured into H2O (360 mL) and extracted with CH2Cl2 (5 x 100 mL). The combined organic layers were washed with H2O (180 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by flash chromatography on silica gel («-hexane/Et2O 1 :1) to afford 6 (6.72O g, 97%) as a colorless solid: mp 34-38 °C lit.4 < 40 °C; [α]22 D +35.1 (c l .03, CHCl3) lit.36 [α]22 D +34.0 (c l.O, CHCl3); 1H NMR (400 MHz, C2D2Cl4, 120 0C): δ 1.47 (s, 9 H), 1.49 (s, 3 H), 1.56 (s, 3 H), 2.63 (dd, J- 7.7, 16.6 Hz, 1 H), 2.88 (dd, J = 4.0, 16.6 Hz, 1 H), 3.70 (bd, J= 9.2 Hz, 1 H), 4.05 (dd, J= 6.0, 9.2 Hz, 1 H), 4.24-4.33 (m, 1 H), 9.77 (bs, 1 H); 13C NMR (100 MHz, C2D2Cl4, 120 0C): δ 24.3 (CH3), 27.1 (CH3), 28.5 (CH3), 48.0 (CH2), 52.8 (CH), 67.8 (CH2), 80.4 (C), 93.9 (C), 151.8 (C), 199.9 (CH).
(4S)- 4- [(2R)- 2- Hydroxy- 3- nitroρropyl]-2,2- dimethyloxazolidine- 3-carboxylic acid tert-butyl ester (12): A
Figure imgf000017_0003
solution of indabox ligand (+)-16 (493 mg, 1.375 mmol) and Cu(OAc)2-H2O (250 mg, 1.25 mmol) in EtOH (37.5 mL) was stirred for I h at room temperature. Nitromethane (13.6 mL, 250.0 mmol) and the aldehyde 6 (6.08 g, 25.0 mmol) were subsequently added to the resulting clear blue solution. After stirring for 5 d at room temperature the solvent was removed in vacuo. The diastereomeric ratio 12:13 was determined by HPLC analysis (n-heptane/i-PrOH 99:1; LiChrospher® 250x4, Si 60, 5 μm; 1.5 mL/min; 215 nm; 13: tr = 33.8 min; 12: tr = 42.4 min) of the crude reaction mixture to be 97:3. The crude product was purified by flash chromatography on silica gel (/?-hexane:EtOAc 3:1) to give 12 (6.87 g, 94%) as a 97:3 mixture of diastereomers. For analytical purposes a small quantity of the diastereomers was separated by preparative HPLC (π-heptane/z-PrOH 99:1; Hibar® 250x25, Si 60, 5 μm, 15 mL/min; 215 nm) to afford 12 as a colorless solid: mp 61-62 °C; [α]22 D +28.9 (c O.56, CH2Cl2); IR (KBr): 3483 cm"1, 1697, 1558, 1394; 1H NMR (500 MHz, C2D2Cl4, 100 0C): δ 1.50 (s, 9 H), 1.51 (s, 3 H), 1.60 (s, 3 H), 1.82-1.94 (m, 2 H), 3.48 (bs, 1 H), 3.79 (dd, J= 1.2, 9.1 Hz, 1 H), 4.02 (dd, J= 6.1, 9.1 Hz, 1 H), 4.06-4.14 (m, 1 H), 4.35-4.42 (m, 1 H), 4.42-4.50 (m, 2 H); 13C NMR (100 MHz, C2D2Cl4, 100 0C): δ 24.2 (CH3), 27.3 (CH3), 28.5 (CH3), 38.8 (CH2), 54.7 (CH), 66.8 (CH), 68.1 (CH2), 80.7 (CH2), 80.9 (C), 94.1 (C), 152.6 (C); MS (CI) m/z (rel. intensity): 305 (1) [M+H]+, 188 (100); Anal. Calcd for C13H24N2O6: C, 51.31 ; H, 7.95; N, 9.20. Found: C, 51.31; H, 7.93; N, 9.04.
(45)-2,2- Dimethyl- 4- [(2R)-2-triisopropylsilanyloxy-3- o TlPSO BocN-/ — nitropropyl]-oxazoIidine-3-carboxylic acid tert-huty\ ester (19):
TIPSOTf (1.5 mL, 5.25 mmol) was added dropwise to a cooled solution (0 0C) of alcohol 12 (1.52 g, 5.0 mmol, 97:3 mixture of diastereomers) and 2,6-Lutidine (680 μl, 5.75 mmol) in CH2Cl2 (1O mL). The reaction mixture was stirred for 90 min at 0 0C and for 15 h at room temperature before it was quenched with saturated aqueous NaHCO3. The layers were separated and the aqueous layer was extracted with diethyl ether (5 x 20 mL). The combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel («-hexane:EtOAc 85:15) to afford TIPS-ether 19 (2.252 g, 98%) as a 97:3 mixture of diastereomers: IR (film): 1688 cm"1, 1556, 1388; 1H NMR (500 MHz, CD2Cl2): δ 1.05 (bs, 21 H), 1.46 (s, 9 H), 1.47 (s, 3 H), 1.56 (s, 3 H), 1.80-1.87 (m, 1 H), 2.06 (m, 1 H), 3.69 (bd, J= 8.4 Hz, 1 H), 3.80-4.02 (m, 2 H), 4.44-4.60 (m, 1 H), 4.65 (dd, J= 6.3, 11.8 Hz, 1 H), 4.87 (bd, J= 11.8 Hz, 1 H); 13C NMR (125 MHz, CD2Cl2): δ 13.0 (CH), 18.2 (CH3), 24.5 (CH3), 28.2 (CH3), 28.5 (CH3), 42.0 (CH2), 54.4 (CH), 68.4 (CH), 68.7 (CH2), 80.72 (CH2), 80.75 (C), 94.3 (C), 153.5 (C); HRMS (FAB) calcd for C22H45N2O6Si [M+H]+: 461.3047. Found: 461.3051.
(45)- 4- [(2/?)-3-BenzyIoxycarbonylamino-2-triisopropylsiIanyl- oxy-propyl]-2,2-dimethyloxazolidine-3-carboxylic acid tert-bntyλ
Figure imgf000018_0001
ester (17): Ammonium formate (3.083 g, 48.9 mmol) and palladium on carbon (10% Merck, 593 mg) were subsequently added to a cold (0 0C) stirred solution of the nitro derivative 19 (2.23O g, 4.84 mmol, 97:3 mixture of diastereomers) in MeOH (26 mL). After stirring the reaction mixture for 24 h at room temperature, the catalyst was removed by filtration and the filtrate was concentrated in vacuo. The residue was dissolved in CH2Cl2 (50 mL) and washed with saturated aqueous NaHCO3 (20 mL). The organic layer was dried (MgSO4), filtered and concentrated in vacuo to give the crude amine [2.038 g, 1H NMR (400 MHz, CDCl3): δ 1.05 (bs, 21 H), 1.46 (bs, 12 H), 1.54 (s, 0.6 x 3 H), 1.59 (s, 0.4 x 3 H), 1.68-1.90 (m, 1 H), 1.90- 2.10 (m, 1 H), 2.67-2.87 (m, 1 H), 2.93 (dd, J= 7.1 Hz, 12.6 Hz, 1 H), 3.80-3.92 (m, 3 H), 3.99-4.08 (m, 1 H)] which was used without further purification in the next step. N-(Benzyloxy-carbonyloxy)succinimide (1.24 g, 4.88 mmol) was added to a solution of the crude amine and Et3N (850 μl, 6.04 mmol) in CH2Cl2 (15 mL). After stirring for 70 h at room temperature the reaction mixture was diluted with EtOAc (50 mL) and washed with phosphate buffer pH 5.5 (30 mL). The organic layer was dried (MgSO4), filtered and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel («-hexane:EtOAc 85:15) to afford 17 (2.252 g, 82%), which was judged to be diastereomerically pure by 1H NMR (500 MHz), as a colorless oil: [α]24 D +31.2 (c O.49, CH2Cl2); IR (film): 3339 cm"1, 1728, 1698, 1672, 1513; 1H NMR (500 MHz, CH2Cl2): δ 1.07 (bs, 21 H), 1.44 (bs, 3 H), 1.46 (bs, 9 H), 1.52 (bs, 3 H), 1.77-1.96 (m, 2 H), 3.02- 3.22 (m, 1 H), 3.47-3.82 (m, 2 H), 3.83-4.16 (m, 3 H), 5.07 (bs, 2 H), 6.14 (bs, 1 H), 7.25-7.44 (m, 5 H); 13C NMR (125 MHz, CH2Cl2): δ 12.5 (CH), 18.0 (CH3), 24.2 (CH3), 27.6 (CH3), 28.2 (CH3), 38.4 (CH2), 44.3 (CH2), 53.4 (CH), 66.2 (CH2), 68.9 (CH), 69.0 (CH2), 80.3 (C), 93.1 (C), 127.6 (CH), 127.8 (CH), 128.4 (CH), 137.5 (C), 152.7 (C), 156.6 (C); HRMS (FAB) calcd for C30H53N2O6Si [M+H]+: 565.3673. Found: 565.3688.
/«s >v /s (25,4R)-l-Hydroxy-4-triisopropyIsilanyIoxy-5-benzyloxycarbonyl-
ZHN jj jf OH
TiPSO NHBoc aminopent-2-ylaniinocarboxylic acid tert-butyl ester (20): A solution of oxazolidine 17 (565 mg, 1.0 mmol) in THF (12 mL) was treated with anhydrous ethylene glycol (558 μl, 10.0 mmol) and (±)-camphorsulfonic acid (17.0 mg, 0.05 mmol) and was stirred at 50 0C for 48 h. The reaction mixture was cooled to 0 °C, quenched by the addition of saturated aqueous NaHCO3 (10 mL) and diluted with EtOAc (20 mL). The aqueous layer was extracted with EtOAc (3 x 20 mL). The combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel («-hexane:EtOAc 75:25) to afford 20 (336 mg, 64%) as a colorless oil along with recovered starting material 17 (187 mg, 33%): [α] D +15.5 (c 2.46, CH2Cl2); IR (film): 3445 cm"1, 3348, 1710, 1696, 1514; 1H NMR (500 MHz, CHCl3): δ 1.06 (bs, 21 H), 1.43 (bs, 9 H), 1.60-1.70 (m, 1 H), 1.71-1.83 (m, 1 H), 2.78 (bs, 1 H), 3.20 (dt, J = 4.8, 14.0 Hz, 1 H), 3.38-3.68 (m, 3 H), 3.73 (m, 1 H), 3.96-4.09 (m, 1 H), 4.91 (bs, 1 H), 5.07 (d, J= 12.2 Hz, 1 H), 5.12 (d, J= 12.2 Hz, 1 H), 5.41 (bs, 1 H), 7.27-7.40 (m, 5 H); 13C NMR (125 MHz, CHCl3): δ 12.4 (CH), 18.1 (CH3), 28.3 (CH3), 36.7 (CH2), 45.1 (CH2), 49.7 (CH), 65.9 (CH2), 66.7 (CH2), 69.3 (CH), 79.6 (C), 128.0 (CH), 128.1 (CH), 128.5 (CH), 136.6 (C), 156.1 (C), 156.9 (C); HRMS (FAB) calcd for C27H49N2O6Si [M+H]+: 525.3360. Found: 525.3356.
/\ >^\ .CO2H (2S,4R)- 5-BenzyloxycarbonyIamino-2- fert-butoxycarbonyl- TIPSO NHBoc amino-4-triisopropylsilanyloxy-pentanoic acid (4): A catalytic amount of TEMPO (17.8 mg, 0.112 mmol) was added to a solution of alcohol 20 (839.6 mg, 1.6 mmol) in MeCN (8 mL) and sodium phosphate buffer pH 6.7 (6 mL). The mixture was heated to 35 0C, and 2.0 M NaClO2 (1.3 mL) and diluted bleach (730 μl, 0.034 mmol free chlorine) were added simultaneously over 1 h (Caution! Do not mix bleach and NaClO2 before being added to the reaction mixture).37 The reaction mixture was stirred at 35 0C for another 4.5 h and then cooled to room temperature. H2O (28 mL) was added and the pH was adjusted to 8-9 with 4 M NaOH. Then the mixture was poured into cold (0 0C) 0.5 M Na2SO3 (60 mL). After 30 min the mixture was extracted with EtOAc (6 x 80 mL). The combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel (n- hexane/EtOAc 6:4 + 0.5% HOAc) to afford 4 (719 mg, 83%) as a colorless solid: mp 45-47 °C; [α]22 D +67.6 (c 1.64, CH2Cl2); IR (KBr): 3369 cm-1, 1716, 1514; 1H NMR (400 MHz, C2D2Cl4, 80 0C): δ 1.08 (s, 21 H), 1.45 (s, 9 H), 1.86 (m, 1 H), 2.03-2.14 (m, 1 H), 3.22 (dt, J= 5.3, 14.3 Hz, 1 H), 3.71 (m, 1 H), 4.15 (m, 1 H), 4.39 (m, 1 H), 5.11 (d, J= 12.6 Hz, 1 H), 5.15 (d, J= 12.6 Hz, 1 H), 5.45 (bd, J = 4.9 Hz, 1 H), 5.52 (bs, 1 H), 7.26-7.40 (m, 5 H); 13C NMR (100 MHz, C2D2Cl4, 80 0C): δ 12.5 (CH), 18.1 (CH3), 28.4 (CH3), 37.3 (CH2), 44.8 (CH2), 50.7 (CH), 67.2 (CH2), 69.4 (CH), 80.7 (C), 127.9 (CH), 128.2 (CH), 128.6 (CH), 136.4 (C), 155.9 (C), 157.6 (C), 172.9 (C); MS (ESI) m/z (rel. intensity): 539.5 (23) [M+H]+, 561 (100) [M+Na]+; Anal. Calcd for C27H46N2O7Si: C, 60.19; H, 8.61; N, 5.20. Found: C, 60.39; H, 8.81; N, 5.19. O (3S,5Λ)-I5-(Benzyloxycarbonylaminomethyl)-2-oxotetrahydro-
*if o furan-3-yI]carbamic acid tert-buty\ ester (18): A solution of the
*-NHZ carboxylic acid 4 (51 mg, 0.095 mmol) in a mixture of THF (0.4 mL), H2O (0.4 mL) and AcOH (1.2 mL) was stirred at 60 0C for 3 d. The reaction mixture was cooled to room temperature, diluted with H2O (2 mL) and extracted with EtOAc (3 x 10 mL). The combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by flash chromatography on silica gel (n- hexane/EtOAc 1 :1) to afford 18 (18 mg, 51%) as a colorless solid: mp 148-149 0C lit.38 143- 145 0C; [Ct]23 D -25.2 (c 0.85, CHCl3) lit. [α]22 D -22.4 (c 0.5, CHCl3); 1H NMR (500 MHz, CHCl3): δ 1.46 (bs, 9 H), 2.27-2.41 (m, 1 H), 2.43-2.57 (m, 1 H), 3.37 (dt, J= 6.4, 14.7 Hz, 1 H), 3.48-3.60 (m, 1 H), 4.18-4.31 (m, 1 H), 4.64-4.83 (m, 1 H), 4.99-5.19 (m, 3 H), 5.22 (bs, 1 H), 7.31-7.41 (m, 5 H); 13C NMR (125 MHz, CHCl3): δ 28.3 (CH3), 31.6 (CH2), 44.7 (CH2), 49.6 (CH), 67.2 (CH2), 77.1 (CH), 80.9 (C), 128.2 (CH), 128.3 (CH), 128.6 (CH), 136.2 (C), 155.3 (C), 156.6 (C), 174.9 (C). The spectroscopic data were consistent with those reported.6
(4S)- 4-[(2S)-2- hydroxy-3-nitropropyl]- 2,2-dimethyloxazolidine- 3-carboxylic acid tert-hutyl ester (13): Nitroaldol adduct 13 was
Figure imgf000021_0001
prepared from aldehyde 6 (243 mg, 1.0 mmol) and nitromethane (0.55 mL, 10.0 mmol) in the presence of indabox ligand (-)-16 (19.7 mg, 0.055 mmol) and Cu(OAc)2-H2O (10.0 mg, 0.05 mmol) as described for diastereomer 12. The diastereomeric ratio 13:12 was determined by HPLC analysis (n-heptane//-PrOH 99:1; LiChrospher® 250x4, Si 60, 5 μm; 1.5 mL/min; 215 nm; 13: t,- = 33.8 min; 12: tr = 42.4 min) of the crude reaction mixture to be 92 : 8. The crude product was purified by flash chromatography on silica gel (/j-hexane:EtOAc 3:1) to give 13 (211 mg, 91%) as a 92:8 mixture of diastereomers. For analytical purposes a small quantity of the diastereomers was separated by preparative HPLC (/ι-heptane/ϊ-PrOH 99:1; Hibar® 250x25, Si 60, 5 μm, 15 mL/min; 215 nm) to afford 13 as a colorless solid: mp 58-60 0C; [α]22 D -31.6 (c 1.08, CH2Cl2); IR (KBr): 3408 cm"1, 1661, 1554, 1407; 1H NMR (500 MHz, CDCl3): δ 1.50 (s, 9 H), 1.51 (s, 3 H)5 1.56 (s, 3 H), 1.57-1.64 (m, 1 H), 1.77 (ddd, J= 2.0, 11.3, 13.4 Hz, 1 H), 3.67 (d, J- 8.9 Hz, 1 H), 4.03 (dd, J= 5.5, 8.9 Hz, 1 H), 4.22-4.31 (m, 2 H), 4.33 (dd, J= 4.0, 12.4 Hz, 1 H), 4.46 (dd, J= 8.6, 12.4 Hz, 1 H), 5.13 (bd, J= 3.8 Hz, 1 H); 13C NMR (125 MHz, CDCl3): δ 24.3 (CH3), 28.0 (CH3), 28.3 (CH3), 39.9 (CH2), 53.7 (CH), 65.5 (CH), 68.1 (CH2), 80.1 (CH2), 81.8 (C), 94.1 (C), 154.5 (C); MS (CI) m/z (rel. intensity): 305 (2) [M+H]+, 188 (100); Anal. Calcd for Ci3H24N2O6: C, 51.31; H, 7.95; N, 9.20. Found: C, 51.39; H, 7.94; N, 9.14. (45)-2,2-Dimethyl-4-{(2S)-2-triisopropylsilanyIoxy-3-nitropropyl]-
O TlPSO BocN-/ — oxazolidine-3-carboxylic acid tert-butyl ester (21): Silylether 21 was prepared from nitroaldol adduct 13 (1.035g, 3.4 mmol) as described for diastereomer 19. Flash chromatography on silica gel (w-hexane/EtOAc 90:10) of the crude product afforded 21 (1.517 g, 97%) as a 92:8 mixture of diastereomers: IR (film): 1699 cm"1, 1558, 1389; 1H NMR (400 MHz, CD2Cl2): δ 1.07 (bs, 21 H), 1.48 (bs, 12 H), 1.56 (s, 3 H), 1.79-2.01 (m, 2 H), 3.58-3.91 (m, 2 H), 3.91-4.04 (m, 1 H), 4.33-4.38 (m, 1 H), 4.48- 4.80 (m, 2 H); 13C NMR (100 MHz, CD2Cl2): δ 13.0 (CH), 18.2 (CH3), 24.4 (CH3), 27.7 (CH3), 28.5 (CH3), 40.4 (CH2), 55.1 (CH), 67.9 (CH2), 69.1 (CH), 80.6 (C), 81.6 (CH2), 94.0 (C), 152.4 (C); HRMS (FAB) calcd for C22H45N2O6Si [M+H]+: 461.3047. Found: 461.3053.
(4S)-4-[(2S)-3-Benzyloxycarbonylamino-2-triisopropylsilanyloxy-propyl]-2,2- dimethyloxazolidine-3-carboxyIic acid tert-butyl ester (22): Z- protected amine 22 was prepared from nitro derivative 21 (1.473 g, 3.2 mmol, 92:8 mixture of diastereomers) as described for diastereomer 17. The crude product was purified by flash chromatography on silica gel (n-hexane/EtOAc 85:15) to afford 21 (1.445 g, 80%), which was judged to be diastereomerically pure by 1H NMR (500 MHz), as a colorless oil: [α]2I D +13.7 (c = 0.90, CH2Cl2); IR (film): 3358 cm"1, 1726, 1698; 1H NMR (400 MHz, C2D2Cl4, 120 0C): δ 1.12 (bs, 21 H), 1.53 (bs, 9 H), 1.55. (bs, 3 H), 1.60 (bs, 3 H), 1.80-1.92 (m, 1 H), 1.97-2.11 (m, 1 H), 3.26-3.37 (m, 1 H), 3.38-3.49 (m, 1 H), 3.70-3.88 (m, 1 H), 3.88-4.00 (m, 2 H), 4.00-4.07 (m, 1 H), 5.06 (bs, 1 H), 5.16 (bs, 2 H), 7.31-7.42 (m, 5 H); 13C NMR (100 MHz, C2D2Cl4, 12O 0C): δ = 12.8 (CH), 18.1 (CH3), 24.3 (CH3), 27.2 (CH3), 28.6 (CH3), 39.8 (CH2), 47.1 (CH2), 55.4 (CH), 66.6 (CH2), 67.7 (CH2), 70.1 (CH), 79.9 (C), 93.4 (C), 127.7 (CH), 127.9 (CH), 128.4 (CH), 137.1 (C), 151.8 (C), 156.4 (C); HRMS (FAB) calcd for C30H53N2O6Si [M+H]+: 565.3673. Found: 565.3676.
/\/\^^ (25,4S)-l-Hydroxy-4-triisopropylsilanyloxy-5-benzyloxycarbo-
ZHN ;[ jf OH
TlPSO NHBoc nyl-aminopent-2-ylaminocarboxylic acid tert-butyl ester (23): A solution of 22 (1.412 g, 2.5 mmol) and pyridinium /7-toluene sulfonate (377 mg, 1.5 mmol) in dry MeOH (20O mL) was stirred at 60 0C for 4.5 h. The reaction mixture was cooled to room temperature and the solvent was removed in vacuo. The residue was dissolved in EtOAc (300 mL) and washed with saturated aqueous NaHCO3. The organic layer was dried (MgSO4), filtered, and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel («-hexane:EtOAc 75:25) to afford 23 (994 mg, 76%) as a colorless oil along with recovered starting material 22 (300 mg, 21%): [α]23 D -16.0 (c 0.75, CH2Cl2); IR (film): 3345 cm"1, 1710, 1700; 1H NMR (500 MHz, CHCl3): δ 1.07 (bs, 21 H), 1.43 (s, 9 H), 1.65 (ddd, J = 5.0, 9.9, 14.6 Hz, 1 H), 1.74 (dt, J = 4.7, 14.6 Hz, 1 H), 3.13 (bs, 1 H), 3.22 (dt, J = 4.9, 14.0 Hz, 1 H), 3.42 (m, 1 H), 3.48-3.66 (m, 2 H), 3.77 (bs, 1 H), 4.09 (bs, 1 H), 5.08 (d, J = 12.5 Hz, 1 H), 5.12 (d, J = 12.5 Hz, 1 H), 5.12-5.18 (m, 1 H), 5.43 (bs, 1 H), 7.29-7.40 (m, 5 H); 13C-NMR (125 MHz, CDCl3): δ 12.5 (CH), 18.1 (CH3), 28.3 (CH3), 35.3 (CH2), 46.2 (CH2), 50.4 (CH), 66.9 (CH2), 67.0 (CH2), 69.4 (CH), 79.7 (C), 128.1 (CH), 128.2 (CH), 128.5 (CH), 136.5 (C), 156.7 (C), 156.8 (C); HRMS (FAB) calcd for C27H49N2O6Si [M+H]+: 525.3360. Found: 525.3401.
,CO2H (2S,4S)-5-Benzyloxycarbonylamino-2-fer/-butoxycarbonylainino-
ZHN
TIPSO NHBoc 4-triisopropyIsπanyloxy-pentanoic acid (5): Carboxylic acid 5 was prepared from alcohol 23 (787 mg, 1.5 mmol) by oxidation with
NaClO2 in the presence of catalytic TEMPO and NaOCl as described for diastereomer 4. The crude reaction product was purified by flash chromatography on silica gel (π-hexane/EtOAc 60:40 + 0.5 % HOAc) to afford 5 (719 mg, 89%) as a colorless solid: mp 53-55 0C; [α]20 D - 28.5 (c l .00, CH2Cl2); IR (KBr): 3350 cm'1, 1719, 1517; 1H NMR (500 MHz, C2D2Cl4, 80 0C): δ 1.10 (s, 21 H), 1.47 (s, 9 H), 1.92 (m, 1 H), 2.10 (m, 1 H), 3.27 (m, 1 H), 3.43 (m, 1 H), 4.16 (bs, 1 H), 4.34 (bs, 1 H), 5.07-5.18 (m, 3 H), 5.42 (bs, 1 H), 1.29-1 Al (m, 5 H); 13C NMR (125 MHz, C2D2Cl4, 80 0C): δ 12.7 (CH), 18.1 (CH3), 28.4 (CH3), 36.2 (CH2), 46.4 (CH2), 51.3 (CH), 67.0 (CH2), 69.1 (CH), 80.9 (C), 128.0 (CH), 128.2 (CH), 128.6 (CH), 136.6 (C), 156.3 (C), 156.7 (C), 174.0 (C); HRMS (FAB) calcd for C27H47N2O7Si [M+H]+: 539.3153. Found: 539.3154. For 1H NMR see Figures.
1 (a) Sulser, H.; Stute, R. Experientia 1976, 32, 422-423. (b) Rozan, P.; Kuo, Y.-H.; Lambein, F. Phytochemistry 2001, 58, 281-289.
2 (a) Bell, E. A.; Tirimanna, A. S. L. Biochem. J. 1964, 356-358. (b) Hatanaka, S.; Kaneko, S.; Saito, K.; Ishida, Y. Phytochemistry (Elsevier) 1981, 20, 2291-2292.
3 Pruess, D. L.; Kellett, M. J. Antibiotics 1983, 36, 208-212.
4 (a) Martin, J. H.; Mitscher, L. A.; Shu, P.; Porter, J. N.; Bohonos, N.; DeVoe, S. E.; Patterson, E. L. Antimicrob. Agents Chemother. -1967 1968, 422-425. (b) Ezaki, M.; Iwami, M.; Yamashita, M.; Hashimoto, S.; Komori, T.; Umehara, K.; Mine, Y.; Kohsaka, M.; Aoki, H.; Imanaka, H. J. Antibiotics 1985, 38, 1453-1461. (c) Chang, C. C; Morton, G. O.; James, J. C; Siegel, M. M.; Kuck, N. A.; Testa, R. T.; Borders, D. B. J. Antibiotics 1991, 44, 674-677.
5 (a) Lampe, T.; Adelt, I.; Beyer, D.; Brunner, N.; Endermann, R.; Ehlert, K.; Kroll, H.-P.; von Nussbaum, F.; Raddatz, S.; Rudolph, J.; Schiffer, G.; Schumacher, A.; Cancho-Grande, Y.; Michels, M.; Weigand, S. WO 2003106480, 2003; Chem. Abstr. 2004, 140, 59934. (b) Lampe, T.; Adelt, I.; Beyer, D.; Brunner, N.; Endermann, R.; Ehlert, K.; Kroll, H.-P.; von Nussbaum, F.; Raddatz, S.; Rudolph, J.; Schiffer, G.; Schumacher, A. VVO 2004012816, 2004; Chem. Abstr. 2004, 140, 164239.
6 Paintner, F. F.; Gorier, K.; Voelter, W. Synlett 2003, 522-526.
7 (a) Hammarsten, E. Compt. Rend. Trav. Lab. Carlsberg, 1916, 11, 223-262. (b) Talbot, G.; Gaudry, R.; Berlinguet, L. Can. J. Chem. 1956, 34, 911-914. (c) Mizusaki, K.; Makisumi, S. Bull. Chem. Soc. Jpn. 1981, 54, 470-472. (d) Jackson, R. F. W.; Wood, A.; Wythes, M. J. Synlett 1990, 735-736. (e) Hausler, J. Liebigs Ann. Chem. 1992, 1231-1237. (f) Jackson, R. F. W.; Rettie, A. B.; Wood, A.; Wythes, M. J. J. Chem. Soc, Perkin Trans. 1 1994, 1719-1726. (g) Girard, A.; Greek, C; Genet, J. P. Tetrahedron Lett. 1998, 39, 4259-4260. (h) Mues, H.; Kazmaier, U. Synthesis 2001, 487-498. (i) Lepine, R.; Carbonnelle, A.-C; Zhu, J. Synlett 2003, 1455-1458.
8 Schmidt, U.; Meyer, R.; Leitenberger, V.; Stabler, F.; Lieberknecht, A. Synthesis 1991, 409-413.
9 Rudolph, J.; Hanning, F.; Theis, H.; Wischnat, R.; Org. Lett. 2001, 3, 3153-3155.
10 For recent use of this versatile chiral building block see: (a) Dondoni, A.; Massi, A.; Minghini, E.; Sabbatini, S.; Bertolasi, V. J. Org. Chem. 2003, 68, 6172-6183. (b) Catalano, J. G.; Deaton, D. N.; Furfine, E. S.; Hassell, A. M.; McFayden, R. B.; Miller, A. B-.; Miller, L. R.; Shewchuk, L. M.; Willard, D. H.; Whright, L. L. Bioorg.Med. Chem. Lett. 2004, 14, 275-278. (c) Dondoni, A.; Catozzi, N.; Marra, A. J. Org. Chem. 2004, 69, 5023-5036. (d) Dondoni, A.; Giovanni, P. P.; Massi, A.; Org. Lett. 2004, 6, 2929-2932.
11 An analogous Henry reaction based strategy for the synthesis of 4-hydroxyornithine was previously reported by Rudolph et al. (ref. 9). This approach, however, suffers both from an unfavorable stereoselectivity and from a very low yield in the key nitroaldol reaction step and therefore was not pursued further.
12 Although Λ/-Boc-protected (S)-2-amino-1 ,4-butandiol 7 is commercially available (Aldrich), its relatively high price leads to recommend its preparation on a multigram scale from inexpensive L- aspartic acid (see Supporting Information).
13 Ksander, G.; de Jesus, R.; Yuan, A.; Ghai, R. D.; Trapani, A.; McMartin, C; Bohacek, R. J. Med. Chem. 1997, 40, 495-505.
14 For an alternative approach to 6 starting from /V-terf-butoxy-carbonyl-L-aspartic acid γ-benzyl ester see: Ouerfelli, O.; Ishida, M.; Shinozaki, H.; Nakanishi, K.; Ohfune, Y. Synlett 1993, 409-410.
15 Hou, D.-R.; Reibenspies, J. H.; Burgess, K. J. Org. Chem. 2001, 66, 206-215.
16 Ab initio MO calculations (DFT/B3LYP/6-311 G+) showed an energy difference of about 7.8 kcal/mol between 9 and the six-membered cyclic Λ/,O-acetal 10 indicating that only traces of this regioisomer are to be expected.
17 Products 8, 9 and 11 were obtained in a ratio of 30:45:25 (as determined by 1H NMR analysis of the crude reaction product) by treatment of 7 with DMP (10 equiv.) and TsOH (0.1 equiv., CH2CI2, rt, 36h) according to lit. 15.
18 Youn, S. W.; Kim, Y. H. Synlett 2000, 880-882.
19 Ohrlein, R.; Jager, V. Tetrahedron Lett. 1988, 29, 6083-6086.
20 Hanessian, S.; Brassard, M. Tetrahedron 2004, 60, 7621-7628.
21 Low stereoselectivity in nitroaldol reactions with aldehydes bearing a stereogenic center at the β- position has been observed previously. See: ref. 9 and references cited therein.
22 (a) Sasai, H.; Suzuki, T.; Arai, S.; Shibasaki, M. J. Am. Chem. Soc. 1992, 114, 4418-4420. (b) Sasai, H.; Watanabe, S.; Suzuki, T.; Shibasaki, M. Org. Synth. 2002, 78, 14-22.
23 Corey, E. J.; Zhang, F.-Y. Angew. Chem., Int. Ed. 1999, 38, 1931-1934.
24 Ooi, T.; Doda, K.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 2054-2055. 25 (a) Trost, B. M.; Yeh, V. S. C; Ito, H.; Bremeyer, N. Org. Lett. 2002, 4, 2621-2623. (b) Trost, B. M.; Yeh, V. S. C. Angew. Chem., Int. Ed. 2002, 41, 861-863.
26 (a) Kogami, Y.; Nakajima, T.; Ashizawa, T.; Kezuka, S.; Ikeno, T.; Yamada, T. Chem. Lett. 2004, 33, 614-615. (b) Kogami, Y.; Nakajima, T.; Ikeno, T.; Yamada, T. Synthesis 2004, 1947-1950.
27 (a) Christenseπ, C; Juhl, C; Jørgensen, K. A. Chem. Commun. 2001, 2222-2223. (b) Risgaard, T.; Gothelf, K. V.; Jørgensen, K. A. Org. Biomol. Chem. 2003, 1, 153-156.
28 Evans, D. A.; Seidel, D.; Rueping, M.; Lam, H. W.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2003, 125, 12692-12693.
29 Since β-nitro alcohols 12 and 13 were difficult to separate, 12 was used as a mixture of diastereomers (97 : 3). The minor diastereomer could be easily removed by flash chromatography on silica gel at the stage of the Λ/s-Z-protected β-amino alcohol 17.
30 Since β-nitro alcohols 12 and 13 were difficult to separate, 12 was used as a mixture of diastereomers (97 : 3). The minor diastereomer could be easily removed by flash chromatography on silica gel at the stage of the Λ/*-Z-protected β-amino alcohol 17.
31 Zhao, M.; Li, J.; Mano, E.; Song, Z.; Tschaen, D. M.; Grabowski, E. J. J. ; Reider, P. J. J. Org. Chem. 1999, 64, 2564-2566.
32 Estiarte, M. A.; Diez, A.; Rubiralta, M.; Jackson, R. F. W. Tetrahedron 2001, 57, 157-161.
33 (a) Evans, D. A.; Burgey, C. S.; Paras, N. A.; Vojkovsky, T.; Tregay, S. W. J. Am. Chem. Soc. 1998, 120, 5824-5825. (b) Kuroso, M.; Porter, J. R.; Foley, M. A. Tetrahedron Lett. 2004, 45, 145-148.
34 (a) Hou, D.-R.; Reibenspies, J. H.; Burgess, K. J. Org. Chem. 2001, 66, 206-215. (b) Ksander, G. M.; de Jesus, R.; Yuan, A.; Ghai, R. D.; Trapani, A.; McMartin, C; Bohacek, R. J. Med. Chem. 1997, 40, 495-505.
35 Collier, P. N.; Campbell, A. D.; Patel, I.; Raynham, T. M.; Richard, Taylor J. K. J. Org. Chem. 2002, 67, 1802-1815.
36 Dondoni, A.; Catozzi, N.; Marra, A. J. Org. Chem. 2004, 69, 5023-5036.
37 Zhao, M.; Li, J.; Mano, E.; Song, Z.; Tschaen, D. M.; Grabowski, E. J. J.; Reider, P. J. J. Org. Chem. 1999, 64, 2564-2566.
38 Estiarte, M. A.; Diez, A.; Rubiralta, M.; Jackson, R. F. W. Tetrahedron 2001, 57, 157-161.

Claims

We claim:
1. A process for the preparation of a compound of formula (I) or its enantiomer
Figure imgf000027_0001
(I) wherein:
R1 is methyl, ethyl, 2,2,2-trichloroethyl, 2-trimethylsilylethyl, tert-bxtXyl, 1-adamantyl, allyl, 9-fluorenylmethyI, benzyl or a substituted benzyl group;
which comprises reacting a compound of formula (II) or its enantiomer:
Figure imgf000027_0002
where R is as defined above, with an appropriate 2,2-dialkoxypropane of formula (III)
Figure imgf000027_0003
(III) wherein: R is methyl or ethyl and with an appropriate 2-alkoxypropene of formula (IV)
Figure imgf000027_0004
(IV) wherein:
R2 is methyl or ethyl, in the presence of an acid to give a compound of formula (V) or its enantiomer
Figure imgf000028_0001
wherein:
R1 and R2 are as defined above, which is hydro lyzed to give a compound of formula (I).
2. Process according to claim 1, wherein the acid is p-toluene sulfonic acid.
3. Process according to any of the preceding claims, wherein R1 is tert-butyl.
4. Process according to any of the preceding claims, wherein R2 is methyl.
5. Process according to any of the preceding claims, wherein the compound of formula (III) is used as the only solvent.
6. The compound of formula (V) or its enantiomer: wherein R and R" are as defined in claim 1.
7. Compound according to claim 6, wherein R1 is tert-butyl.
8. Compound according to any of claims 6 or 7, wherein R is methyl.
PCT/EP2006/002090 2005-03-08 2006-03-07 Apparatus and method for the final processing of a forming tool for a sheet-metal body part Ceased WO2006094770A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05005031.9 2005-03-08
EP05005031 2005-03-08

Publications (2)

Publication Number Publication Date
WO2006094770A2 true WO2006094770A2 (en) 2006-09-14
WO2006094770A3 WO2006094770A3 (en) 2006-11-30

Family

ID=35198017

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/002090 Ceased WO2006094770A2 (en) 2005-03-08 2006-03-07 Apparatus and method for the final processing of a forming tool for a sheet-metal body part

Country Status (1)

Country Link
WO (1) WO2006094770A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009127546A1 (en) 2008-04-16 2009-10-22 F. Hoffmann-La Roche Ag Pyrrolidinone glucokinase activators
WO2024262518A1 (en) * 2023-06-20 2024-12-26 国立大学法人北海道大学 Amino acid compound for scanning, modified peptide for scanning, kit for scanning, and scanning method for active sites in peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472533B1 (en) * 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009127546A1 (en) 2008-04-16 2009-10-22 F. Hoffmann-La Roche Ag Pyrrolidinone glucokinase activators
WO2024262518A1 (en) * 2023-06-20 2024-12-26 国立大学法人北海道大学 Amino acid compound for scanning, modified peptide for scanning, kit for scanning, and scanning method for active sites in peptide

Also Published As

Publication number Publication date
WO2006094770A3 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
KR20210032950A (en) Chemical method for preparing phenylpiperidinyl indole derivatives
KR100849880B1 (en) New process for the preparation of optically active 2-[6-substituted alkyl-1,3-dioxan-4-yl]acetic acid derivatives
Shevchuk et al. New asymmetric approach to β-trifluoromethyl isoserines
Avenoza et al. Enantioselective synthesis of (S)-and (R)-α-methylserines: application to the synthesis of (S)-and (R)-N-Boc-N, O-isopropylidene-α-methylserinals
HU207288B (en) Process for enenthioselective producing phenyl-isoserine derivatives
US4981992A (en) Process for preparing optically active 3-hydroxybutanoic acid
EP0331524A2 (en) Synthesis of trichostatins
EP0333268A1 (en) Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
JP2019503400A (en) Process for producing 3-((2S, 5S) -4-methylene-5- (3-oxopropyl) tetrahydrofuran-2-yl) propanol derivative and intermediate therefor
KR101430116B1 (en) Method for producing chiral α-aminonitrile using catalyst for streaker reaction
WO2006094770A2 (en) Apparatus and method for the final processing of a forming tool for a sheet-metal body part
KR20230107791A (en) Method for producing 4-borono-L-phenylalanine and intermediates thereof
KR20030053026A (en) A process for the synthesis of sphingosine
EP0269236B1 (en) Process for synthesis of a chiral azetidinone
Davoli et al. A novel approach to a precursor of the carbapenem antibiotic PS-5 via aziridine stereospecific carbonylation
JP5102925B2 (en) Synthetic methods for intermediates for ectein and phthalacidins
US6583292B2 (en) Method for the esterification of alcohols and compounds useful therefor as potential anticancer agents
US5380849A (en) Process for optically pure decahydroisoqiunolines
KR100743617B1 (en) Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity
US5591881A (en) Stereoselective preparation of (E)-enolthioether derivatives
US6207847B1 (en) Manufacture of optically active halohydrin trialkylsilyl ethers
JP3726996B2 (en) Cytoxazone synthesis method
JP7568644B2 (en) Diastereoselective methods for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
JP2010195737A (en) Method for producing optically active convolutamydine derivative
Okazaki et al. Total Synthesis and Absolute Configuration Revision of Biofloranate F

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06723272

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6723272

Country of ref document: EP